Current Respiratory Medicine Reviews
Title:Hydroxychloroquine, Arbidol and COVID-19: The Jury is Still Out!
Volume: 17 Issue: 1
Author(s): Elizabeth Gamboa and Joseph Varon*
Affiliation:
- Critical Care Services, United Memorial Medical Center Houston, Texas,United States
Export Options
About this article
Cite this article as:
Gamboa Elizabeth and Varon Joseph *, Hydroxychloroquine, Arbidol and COVID-19: The Jury is Still Out!, Current Respiratory Medicine Reviews 2021; 17 (1) . https://dx.doi.org/10.2174/1573398X1701210504142249
DOI https://dx.doi.org/10.2174/1573398X1701210504142249 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Inhibitors of the Sulfur Assimilation Pathway in Bacterial Pathogens as Enhancers of Antibiotic Therapy
Current Medicinal Chemistry A Possible Placental Factor for Preeclampsia: sFlt-1
Current Medicinal Chemistry Recent Advances in the Development of Agonists Selective for β1-Type Thyroid Hormone Receptor
Mini-Reviews in Medicinal Chemistry Patents Related to Pathogenic Human Coronaviruses
Recent Patents on Biotechnology Proteomic Study of the Mechanism of Talin-C as an Inhibitor of HIV Infection
Current Proteomics “Seeing is Believing”: Perspectives of Applying Imaging Technology in Discovery Toxicology
Combinatorial Chemistry & High Throughput Screening 4-Anilino-3-quinolinecarbonitriles: An Emerging Class of Kinase Inhibitors
Current Topics in Medicinal Chemistry Molecular Docking and 3D-QSAR Studies on Quinolone-based HDAC Inhibitors
Letters in Drug Design & Discovery Assessment of the Antineoplastic Potential of Chalcones in Animal Models
Current Medicinal Chemistry Identification of Potential Mps1 Inhibitors Through Multiple Pharmacophore- based Virtual Screening and Molecular Docking
Letters in Drug Design & Discovery COVID-19 Vaccine-Induced Pro-thrombotic Immune Thrombocytopenia (VIPIT): State of the Art
Current Cardiology Reviews The Nuclear Overhauser Effect in the Lead Identification Process Pharmacophore Models
Current Drug Discovery Technologies Glibenclamide Action on Myocardial Function and Arrhythmia Incidence in the Healthy and Diabetic Heart
Cardiovascular & Hematological Agents in Medicinal Chemistry NMR-based Drug Development and Improvement Against Malignant Melanoma – Implications for the MIA Protein Family
Current Medicinal Chemistry Therapeutic Potential of Adipose-derived Stem Cells in the Treatment of Pulmonary Diseases
Current Stem Cell Research & Therapy Antiviral Strategies Against Human Coronaviruses
Infectious Disorders - Drug Targets Extracellular Vesicles Isolated from Mesenchymal Stromal Cells Primed with Hypoxia: Novel Strategy in Regenerative Medicine
Current Stem Cell Research & Therapy Metabolism-based Drug-drug Interactions in Patients with Chronic Respiratory Diseases: A Review Focusing on Drugs Affecting the Respiratory System
Current Drug Metabolism mTOR, a Potential Target to Treat Autism Spectrum Disorder
CNS & Neurological Disorders - Drug Targets Artificial Intelligence Approaches in Drug Discovery: Towards the Laboratory of the Future
Current Topics in Medicinal Chemistry